Determination of specific receptor sites for platelet activating factor in bovine neutrophils

American Journal of Veterinary Research

Volumn 65, Issue 5, 2004, Pages 628-636

  Burgos, Rafael A ^a   Hidalgo, María A ^a   Matthei, Sabine M ^a   Hermosilla, Ricardo ^b,c   Folch, Hugo ^a   Hancke, Juan L ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGRAPHOLIDE; APAFANT; GINKGOLIDE A; GINKGOLIDE B; GUANINE DERIVATIVE; LIGNAN DERIVATIVE; POLYCLONAL ANTIBODY; RADIOLIGAND; SCHIZANDRIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRITIUM; 14 DEOXYANDROGRAPHOLIDE; 14-DEOXYANDROGRAPHOLIDE; AZEPINE DERIVATIVE; COMPLEMENTARY DNA; CYCLOOCTANE DERIVATIVE; DITERPENE; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GAMMA SCHIZANDRIN; GAMMA-SCHIZANDRIN; GINKGOLIDE; LACTONE; LIGNAN; POLYCYCLIC HYDROCARBON; PRIMER DNA; SCHIZANDRIN A; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; CATTLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; LIGAND BINDING; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL STRAIN HL 60; COMPARATIVE STUDY; DNA SEQUENCE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; KINETICS; METABOLISM; MOLECULAR GENETICS; RADIOASSAY;

ANIMALIA; BOS TAURUS; BOVINAE;

ANIMALS; AZEPINES; BASE SEQUENCE; BLOTTING, WESTERN; CATTLE; CYCLOOCTANES; DITERPENES; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GINKGOLIDES; HL-60 CELLS; HUMANS; KINETICS; LACTONES; LIGNANS; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; POLYCYCLIC COMPOUNDS; RADIOLIGAND ASSAY; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRIAZOLES; TRITIUM;

EID: 3042666391     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.628     Document Type: Article

References (62)

1. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994;56:672-686.
2. Cohen MS. Molecular events in the activation of human neutrophils for microbial killing. Clin Infect Dis 1994;18 (suppl 2):S170-S179.
3. Kitsis E, Weissmann G. The role of the neutrophil in rheumatoid arthritis. Clin Orthop 1991;265:63-72.
4. Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci 1994;307:284-292.
5. Boxer LA, Axtell R, Suchard S. The role of the neutrophil in inflammatory diseases of the lung. Blood Cells 1990;16:25-40; discussion 41-22.
6. 2 activity in bovine neutrophils. Infect Immun 1998;66:1885-1890.
7. Waller KP. Modulation of endotoxin-induced inflammation in the bovine teat using antagonists/inhibitors to leukotrienes, platelet activating factor and interleukin 1 beta. Vet Immunol Immunopathol 1997; 57:239-251.
8. Prescott SM, Zimmerman GA, Stafforini DM, et al. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000; 69:419-445.
9. McClenahan DJ, Fagliari JJ, Evanson OA, et al. Role of inflammatory mediators in priming, activation, and deformability of bovine neutrophils. Am J Vet Res 2000;61:492-498.
10. McClenahan DJ, Evanson OA, Walcheck BK, et al. Association among filamentous actin content, CD11b expression, and membrane deformability in stimulated and unstimulated bovine neutrophils. Am J Vet Res 2000;61:380-386.
11. Swain SD, Bunger PL, Sipes KM, et al. Platelet-activating factor induces a concentration-dependent spectrum of functional responses in bovine neutrophils. J Leukoc Biol 1998;64:817-827.
12. Persson K, Larsson I, Hallen Sandgren C. Effects of certain inflammatory mediators on bovine neutrophil migration in vivo and in vitro. Vet Immunol Immunopathol 1993;37:99-112.
13. McClenahan DJ, Fagliari JJ, Evanson OA, et al. Role of platelet-activating factor in alveolar septal injury associated with experimentally induced pneumonic pasteurellosis in calves. Am J Vet Res 2000;61:248-254.
14. Hwang SB, Lam MH. Species difference in the specific receptors of platelet activating factor. Biochem Pharmacol 1986;35:4511-4518.
15. Hwang SB, Lam MH, Chang MN. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor. J Biol Chem 1986;261:13720-13726.
16. O'Flaherty JT, Surles JR, Redman J, et al. Binding and metabolism of platelet-activating factor by human neutrophils. J Clin Invest 1986;78:381-388.
17. Hwang SB, Lam MH, Shen TY. Specific binding sites for platelet activating factor in human lung tissues. Biochem Biophys Res Commun 1985;128:972-979.
18. Takano T, Honda Z, Watanabe T, et al. Demonstration of platelet activating factor receptor in guinea pig kidney. Biochem Biophys Res Commun 1991;177:54-60.
19. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993;292:617-629.
20. Ostermann G, Lorenz A, Hofmann B, et al. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists. J Lipid Mediat 1991;4:289-298.
21. Hwang SB. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem 1988;263:3225-3233.
22. Hwang SB. High affinity receptor binding of platelet-activating factor in rat peritoneal polymorphonuclear leukocytes. Eur J Pharmacol 1991;196:169-175.
23. Marquis O, Robaut C, Cavero I. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymerphonuclear leukocytes. J Pharmacol Exp Ther 1988;244:709-715.
24. Ng DS, Wong K. Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. Biochem Biophys Res Commun 1988;155:311-316.
25. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999;51:213-340.
26. Honda Z, Nakamura M, Miki I, et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 1991;349:342-346.
27. Chase PB, Halonen M, Regan JW. Cloning of a human platelet-activating factor receptor gene: evidence for an intron in the 5′-untranslated region. Am J Respir Cell Mol Biol 1993;8:240-244.
28. Ye RD, Prossnitz ER, Zou AH, et al. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun 1991;180:105-111.
29. Nakamura M, Honda Z, Izumi T, et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 1991;266:20400-20405.
30. Roth JA, Kaeberle ML. Evaluation of bovine polymorphonuclear leukocyte function. Vet Immunol Immunopathol 1981;2:157-174.
31. Paulson SK, Wolf JL, Novotney-Barry A, et al. Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor. Proc Soc Exp Biol Med 1990;195:247-254.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
33. Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-3108.
34. The BO, Sander FC, Raj JU. Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth. Am J Physiol Heart Circ Physiol 2000;278:H1168-H1176.
35. Asano K, Taniguchi S, Nakao A, et al. Distribution of platelet activating factor receptor mRNA along the rat nephron segments. Biochem Biophys Res Commun 1996;225:352-357.
36. Nakao A, Watanabe T, Bitoh H, et al. cAMP mediates homologous downregulation of PAF receptor mRNA expression in mesangial cells. Am J Physiol 1997;273:F445-F450.
37. Yang W, Diehl JR, Roudebush WE. Comparison of the coding sequence of the platelet-activating factor receptor gene in three species. DNA Seq 2001;12:239-251.
38. Ali H, Richardson RM, Tomhave ED, et al. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation. J Biol Chem 1994;269:24557-24563.
39. Muller E, Dupuis G, Turcotte S, et al. Human PAF receptor gene expression: induction during HL-60 cell differentiation. Biochem Biophys Res Commun 1991;181:1580-1586.
40. Kroegel C, Yukawa T, Westwick J, et al. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxide anion generation in eosinophils. Biochem Biophys Res Commun 1989;162:511-521.
41. Hurst J, Ma X, Bazan HE. PAF binding to a single receptor in corneal epithelium plasma membrane. Invest Ophthalmol Vis Sci 1999;40:790-795.
42. Svetlov S, Nigam S. Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils. Biochem Biophys Res Commun 1993;190:162-166.
43. Ukena D, Dent G, Chanez P et al. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes]. Pneumologie 1990;44(suppl 1):531-532.
44. Herbert JM, Laplace MC, Cailleau C, et al. Effect of SR 27417 on the binding of [3H] PAF to rabbit and human platelets and human polymorphonuclear leukocytes. J Lipid Mediat 1993;7:57-78.
45. LeVan TD, Dow SB, Chase PB, et al. Evidence for platelet-activating factor receptor subtypes on human polymorphonuclear leukocyte membranes. Biochem Pharmacol 1997;54:1007-1012.
46. Ukena D, Dent G, Birke FW, et al. Radioligand binding of antagonists of platelet-activating factor to intact human platelets. FEBS Lett 1988;228:285-289.
47. Gomez J, Bloom JW, Yamamura HI, et al. Characterization of receptors for platelet-activating factor in guinea pig lung membranes. Am J Respir Cell Mol Biol 1990;3:259-264.
48. Hwang SB, Lam MH, Pong SS. Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. J Biol Chem 1986;261:532-537.
49. Agrawal DK, Ali N, Numao T. PAF receptors and G-proteins in human blood eosinophils and neutrophils. J Lipid Mediat 1992;5:101-104.
50. Tahraoui L, Floch A, Mondot S, et al. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. Mol Pharmacol 1988;34:145-151.
51. Korth R, Nunez D, Bidault J, et al. Comparison of three paf-acether receptor antagonist ginkgolides. Eur J Pharmacol 1988;152:101-110.
52. Foldes-Filep E, Braquet P, Filep J. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. Biochem Biophys Res Commun 1987; 148:1412-1417.
53. Ferreira MG, Fonteles MC. Different classes of PAF-antagonists block norepinephrine-induced vascular escape and tachyphylaxis in the isolated rabbit kidney. Res Commun Mol Pathol Pharmacol 1996;94:147-155.
54. Filep J, Foldes-Filep E. Platelet-activating-factor, neutrophil granulocyte function and BN52021. In: Braquet P, ed. Ginkgolides-chemistry, biology, pharmacology and clinical perspectives. Madrid: JP Prous Science Publishers, 1988;151-160.
55. Lee IS, Jung KY, Oh SR, et al. Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. Biol Pharm Bull 1999;22:265-267.
56. Amroyan E, Gabrielian E, Panossian A, et al. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 1999;6:27-31.
57. Burgos RA, Loyola M, Hidalgo MA, et al. Effect of 14-deoxyandrographolide on calcium-mediated rat uterine smooth muscle contractility. Phytother Res 2003;17:1011-1015.
58. Filep JG, Foldes-Filep E. Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophil granulocytes. Eur J Pharmacol 1990;190:67-73.
59. Garcia Rodriguez C, Cundell DR, Tuomanen EI, et al. The role of N-glycosylation for functional expression of the human platelet-activating factor receptor. Glycosylation is required for efficient membrane trafficking. J Biol Chem 1995;270:25178-25184.
60. Tiemann U, Tomek W, Schneider F, et al. Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy. Prostaglandins Other Lipid Mediat 2001;65:125-141.
61. Muller E, Dagenais P, Alami N, et al. Identification and functional characterization of platelet-activating factor receptors in human leukocyte populations using polyclonal anti- peptide antibody. Proc Natl Acad Sci U S A 1993;90:5818-5822.
62. Van de Weerdt ML, Desmecht D, Lekeux P. Effect of platelet-activating factor on bovine pulmonary function. Vet Rec 1997; 141:168-172.